These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 478825)

  • 1. Severe hypermotility during sleep in treatment of cataplexy with clomipramine.
    Bental E; Lavie P; Sharf B
    Isr J Med Sci; 1979 Jul; 15(7):607-9. PubMed ID: 478825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of clomipramine as an REM sleep suppressant in narcolepsy.
    Chen CN
    Postgrad Med J; 1980; 56 Suppl 1():86-9. PubMed ID: 7393833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride.
    Guilleminault C; Raynal D; Takahashi S; Carskadon M; Dement W
    Acta Neurol Scand; 1976 Jul; 54(1):71-87. PubMed ID: 936975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Cataplexy with Clomipramine.
    Shapiro WR
    Arch Neurol; 1975 Oct; 32(10):653-6. PubMed ID: 170899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Narcolepsy].
    Billiard M; Cadilhac J
    Rev Neurol (Paris); 1985; 141(8-9):515-27. PubMed ID: 2868518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
    Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
    Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cataplexy with clomipramine.
    Shapiro WR
    Trans Am Neurol Assoc; 1974; 99():99-102. PubMed ID: 4463568
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cataplexy associated with Gélineau's disease; effect of clomipramine].
    Passouant P; Baldy-Moulinier M; Aussilloux C
    Rev Neurol (Paris); 1970 Jul; 123(1):56-60. PubMed ID: 5516331
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy for cataplexy.
    Houghton WC; Scammell TE; Thorpy M
    Sleep Med Rev; 2004 Oct; 8(5):355-66. PubMed ID: 15336236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine and clomipramine in the treatment of cataplexy.
    Schachter M; Parkes JD
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):171-4. PubMed ID: 6766990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and polygraphic effects of d.1 5 HTP on narcolepsy-cataplexy.
    Autret A; Minz M; Beillevaire T; Degos C; Cathala HP
    Biomedicine; 1977 Jul; 27(5):200-3. PubMed ID: 336110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does memory impairment exist in narcolepsy-cataplexy?
    Aguirre M; Broughton R; Stuss D
    J Clin Exp Neuropsychol; 1985 Feb; 7(1):14-24. PubMed ID: 3980679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history, symptoms and treatment of the narcoleptic syndrome.
    Parkes JD; Baraitser M; Marsden CD; Asselman P
    Acta Neurol Scand; 1975 Nov; 52(5):337-53. PubMed ID: 19899267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
    Scharf MB; Brown D; Woods M; Brown L; Hirschowitz J
    J Clin Psychiatry; 1985 Jun; 46(6):222-5. PubMed ID: 3888969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of imipramine, dexphenmetrazine and amphetaminsulphate upon the clinical and polygraphic picture of narcolepsy-cataplexy.
    Roth B; Faber J; Nevsímalová S; Tosovský J
    Schweiz Arch Neurol Neurochir Psychiatr; 1971; 108(2):251-60. PubMed ID: 4330752
    [No Abstract]   [Full Text] [Related]  

  • 20. [Too weak with laughing].
    Egeler-Peerdeman SM; Visscher F; Taphoorn MJ
    Ned Tijdschr Geneeskd; 1990 Mar; 134(10):465-8. PubMed ID: 2314486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.